Oresund Capital manages investments for private investment funds and separately managed accounts, focusing on the life sciences sector. OC's investment strategy involves taking large, concentrated positions in companies with potential for long-term value creation. OC does not diversify for the purpose of diversification. OC's clients are generally qualified investors, including institutional investors. OC may provide investment advice on other securities and instruments consistent with client objectives.
Fee Structure
Oresund Capital manages investments for private funds and separately managed accounts. The fees are negotiable and vary among clients.
For the Funds, OC typically receives a monthly asset-based management fee calculated as a percentage of each Investor’s capital account or capital commitment, typically between 1.0% and 2.0% annually. OC, or its affiliate, generally receives a performance allocation from the Fund equal to 25% of the net income allocated to each Investor in the Funds for the quarter, subject to a “high water mark” procedure.
From Separate Accounts, OC generally receives management fees that are comparable to those paid by the Fund; however, separate account fee structures are subject to negotiation and may vary from those paid by the Fund. OC may receive a performance fee comparable to those paid by the Funds; however, fee structures are subject to negotiation and may vary from those paid by the Fund. Many separate accounts do not have any performance fee.